Models

Submission ID Name Format Sort Descending Submitter Submitted Modified Certification
DDMODEL00000078 Chalret_2014_Abexinostat PharmML Vincent Croixmarie 2015/12/09 2016/02/12 uncertified model
DDMODEL00000132 Minimal model PharmML Roberto Bizzotto 2015/12/29 2016/05/18 uncertified model
DDMODEL00000002 Friberg_2009_Schizophrenia_Asenapine_PANSS PharmML Zinnia Parra-Guillen 2014/09/24 2016/05/18 uncertified model
DDMODEL00000213 Li_2006_PK_Meropenem_AdultPatients PharmML Lisa Ehmann 2016/08/26 2016/08/30 uncertified model
DDMODEL00000091 Van Cauter C-peptide model PharmML Roberto Bizzotto 2015/12/10 2016/05/18 uncertified model
DDMODEL00000128 Ribba_2012_PCV PharmML Christian Laveille 2015/12/15 2015/12/16 uncertified model
DDMODEL00000229 A model for monoclonal antibody-based targeted therapy of Gemtuzumab Ozogamicin (GO) for acute myeloid leukemia (AML) PharmML Moran Optimata 2016/10/26 2016/11/01 uncertified model
DDMODEL00000106 Krippendorff model for receptor-mediated endocytosis PharmML Zinnia Parra-Guillen 2015/12/11 2016/07/15 uncertified model
DDMODEL00000186 Friberg_2002_Oncology_Paclitaxel_Myelosuppression PharmML Zinnia Parra-Guillen 2016/05/17 2016/08/24 uncertified model
DDMODEL00000129 Peigne_2015_Ivabradine PharmML Vincent Croixmarie 2015/12/16 2016/02/12 uncertified model
Showing 111 to 120 of 151 models
First Previous 12 13 14 15 16 Next Last
 
Help